Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • BrightInsight Selects Lyniate to Enhance Interoperability Strategic Engagement Will Improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight® Platform

    Sep 15, 2022, 10:52 AM by
    Full story
  • Graphene Modification Helps to Unlock New Potentials

    Sep 15, 2022, 10:36 AM by
    Full story
  • Accelerated Shelf-Life Testing to Assess Drug Stability

    Sep 15, 2022, 10:35 AM by
    Full story
  • Four Most Commonly Used Surfactants You Should Know

    Sep 15, 2022, 10:35 AM by
    Full story
  • Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

    Sep 15, 2022, 10:34 AM by
    Full story
  • BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

    Sep 15, 2022, 10:29 AM by
    XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.
    Full story
  • Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

    Sep 15, 2022, 10:28 AM by
    Molecular Devices and HeartBeat.bio AG have entered into a co-development agreement to commercialize a first-of-its-kind automated offering that will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery.
    Full story
  • Mount Sinai Aims To Enroll One Million People In Genetic Sequencing Project

    Sep 15, 2022, 01:00 AM by User Not Found
    Bio-IT World | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.
    Full story
  • Public More Protective Of Their Health Information Than Their Biospecimens

    Sep 14, 2022, 01:00 AM by User Not Found
    Bio-IT World | In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information.
    Full story
  • Digestive Hormones Found to Significantly Influence Infectious Wound Healing

    Sep 13, 2022, 01:00 AM by User Not Found
    Bio-IT World | The University of Calgary research team discovered that neutrophils and monocytes—two types of white blood cells—play distinct roles in wound healing, with digestive hormones contributing to immune function.
    Full story
  • BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research

    Sep 12, 2022, 11:10 AM by
    BOC Sciences' monthly report released in August showed that its peptide products had vastly facilitated the R&D of cardiovascular therapies.
    Full story
  • Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

    Sep 12, 2022, 11:10 AM by
    Full story
  • DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program

    Sep 12, 2022, 11:09 AM by
    DNAnexus awarded a 3-year contract by Our Future Health to provide a scalable, cloud-based trusted research environment for the large-scale population research program that aims to recruit up to 5 million volunteers. Approved researchers from the global life sciences, healthcare, and academic communities will be able to use the DNAnexus platform to securely explore and analyze the de-identified data.
    Full story
  • BOC Sciences August Promotion: Comprehensive Labeled Peptides with Stable Quality

    Sep 12, 2022, 11:09 AM by
    As a pioneer in stable isotopic labeling chemistry, BOC Sciences develops a large variety of SIL compounds. Its promotion of labeled peptides, the increasingly used materials for convenient detection in research, is on the boil in August.
    Full story
  • BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therapeutics

    Sep 12, 2022, 10:49 AM by
    BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic.
    Full story
  • BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery

    Sep 12, 2022, 10:48 AM by
    As the leading expert in computer-aided drug discovery, BOC Sciences has developed compound docking technologies to facilitate the discovery of novel ligands for over 30 targets.
    Full story
  • BioIVT Highlights ADME-Tox Research Advances at ISSX/MDO 2022

    Sep 9, 2022, 09:45 AM by
    BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, is highlighting recent ADME-Tox research at the 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX) and 24th International Symposium on Microsomes and Drug Oxidations (MDO). This conference will be held from September 11-14 at the Westin Seattle.
    Full story
  • Verana Health to Highlight the Value of Curated Real-World Data at the American College of Epidemiology 2022 Annual Meeting

    Sep 9, 2022, 09:44 AM by
    Research projects demonstrate the value of using quality, de-identified real-world data (RWD) curated from electronic health records (EHRs) to derive actionable insights about missing data. Researchers used de-identified RWD from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) and the American Academy of Neurology Axon Registry®.
    Full story
  • Geneticists Discover Maternal Proteins with Epigenetic Influence Over Fetal Development

    Sep 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | Walter and Eliza Hall Institute geneticists recently discovered that epigenetic information passes from murine mother to child and has lasting effects on development and growth.
    Full story
  • VERICHEM NOW OFFERS MULTI-LEVEL, LIQUID STABLE CLINICAL REFERENCE MATERIALS FOR ETHANOL TESTING

    Sep 7, 2022, 17:34 PM by
    Full story
  • «
  • 121
  • 122 (current)
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy